7.21
Teladoc Health Inc stock is traded at $7.21, with a volume of 8.24M.
It is down -2.57% in the last 24 hours and down -17.22% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$7.40
Open:
$7.27
24h Volume:
8.24M
Relative Volume:
1.22
Market Cap:
$1.26B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.2496
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
-12.07%
1M Performance:
-17.22%
6M Performance:
-29.04%
1Y Performance:
-23.54%
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TDOC
Teladoc Health Inc
|
7.21 | 1.31B | 2.59B | -981.73M | 206.95M | -5.77 |
![]()
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-25-25 | Initiated | Mizuho | Neutral |
Nov-15-24 | Initiated | Goldman | Buy |
Sep-17-24 | Reiterated | Jefferies | Hold |
Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
Jan-03-24 | Initiated | Barclays | Overweight |
Apr-12-23 | Initiated | Stephens | Equal-Weight |
Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
Aug-12-22 | Initiated | DA Davidson | Buy |
Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
Jul-28-22 | Downgrade | Needham | Buy → Hold |
Jul-06-22 | Reiterated | BofA Securities | Neutral |
May-05-22 | Downgrade | Argus | Buy → Hold |
Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-01-22 | Resumed | Credit Suisse | Outperform |
Mar-03-22 | Upgrade | Argus | Hold → Buy |
Feb-23-22 | Reiterated | BofA Securities | Neutral |
Feb-23-22 | Reiterated | Craig Hallum | Hold |
Feb-23-22 | Reiterated | Evercore ISI | In-line |
Feb-23-22 | Reiterated | Goldman | Buy |
Feb-23-22 | Reiterated | JP Morgan | Overweight |
Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
Feb-23-22 | Reiterated | Needham | Buy |
Feb-23-22 | Reiterated | Oppenheimer | Outperform |
Feb-23-22 | Reiterated | Stifel | Hold |
Feb-11-22 | Initiated | Goldman | Buy |
Feb-08-22 | Reiterated | Piper Sandler | Overweight |
Dec-02-21 | Resumed | Jefferies | Hold |
Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
Oct-28-21 | Reiterated | Barclays | Equal Weight |
Oct-28-21 | Reiterated | BofA Securities | Neutral |
Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
Oct-28-21 | Reiterated | Citigroup | Buy |
Oct-28-21 | Reiterated | Craig Hallum | Hold |
Oct-28-21 | Reiterated | Needham | Buy |
Oct-28-21 | Reiterated | Oppenheimer | Outperform |
Oct-28-21 | Reiterated | Piper Sandler | Overweight |
Oct-28-21 | Reiterated | UBS | Neutral |
Oct-19-21 | Initiated | Wells Fargo | Overweight |
Aug-02-21 | Downgrade | Argus | Buy → Hold |
Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
May-28-21 | Initiated | Robert W. Baird | Neutral |
Apr-15-21 | Initiated | Needham | Buy |
Jan-07-21 | Initiated | BTIG Research | Buy |
Dec-22-20 | Initiated | Evercore ISI | In-line |
Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Dec-04-20 | Initiated | Goldman | Neutral |
Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-22-20 | Initiated | DA Davidson | Buy |
Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Jul-14-20 | Initiated | Citigroup | Buy |
Jul-13-20 | Initiated | Argus | Buy |
Jul-07-20 | Initiated | Stephens | Overweight |
Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-13-20 | Initiated | SVB Leerink | Outperform |
Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-10-20 | Initiated | UBS | Neutral |
Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc beats Wall Street expectations in Q2 amid strategic revamp - Healthcare Dive
How does Teladoc Health Inc. generate profit in a changing economyLow Risk Watchlist With High Returns - jammulinksnews.com
Teladoc Health rises on results beat, guidance announcement - MSN
Teladoc Health, Inc. (NYSE:TDOC) Q2 2025 Earnings Call Transcript - Insider Monkey
The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On Teladoc Health, Inc.'s (NYSE:TDOC) Second-Quarter Report - Yahoo Finance
Teladoc Health likely to post a Q2 loss and year-over-year decline in revenue - MSN
Teladoc Health Inc. stock chart pattern explainedLong Hold Safe Return Strategy Reviewed - metal.it
Teladoc (TDOC) Q2 Revenue Tops Estimates - AOL.com
Teladoc Inc. Earnings Call: Growth Amid Challenges - MSN
Is it the right time to buy Teladoc Health Inc. stockFinancial News Report For Fast Growth - jammulinksnews.com
Teladoc Health 2025 Q2 Earnings Net Income Surges 96.1% - AInvest
Teladoc (TDOC) Q2 Revenue Tops Estimates - The Motley Fool
Teladoc Health, Inc. SEC 10-Q Report - TradingView
Teladoc (TDOC) Stock Is Up, What You Need To Know - TradingView
Teladoc Health: Still Struggling To Find A Catalyst (NYSE:TDOC) - Seeking Alpha
Teladoc stock holds steady as Stifel maintains $8 price target - Investing.com
Digital Health Market is evolving rapidly Through 2025 To 2032 | - openPR.com
Teladoc Health Q2 2025 net loss hits USD 32.7 million - Medical Buyer
Needham reiterates Hold rating on Teladoc stock after Q2 results By Investing.com - Investing.com UK
Teladoc Beats Estimates But Faces Sliding Revenue And Mixed Outlook - Finimize
Teladoc Health Earnings: Not Dead Yet (NYSE:TDOC) - Seeking Alpha
Telemedicine Technology Markets Analysis Report 2025 | Market to Surpass $250 Billion by 2030, Driven by Virtual Consultations, Government Investment, and Emerging AI- and IoT-Powered Care Platforms - GlobeNewswire
Teladoc Health Inc (TDOC) Q2 2025 Earnings Call Highlights: Strong Integrated Care Growth Amid ... By GuruFocus - Investing.com Canada
Teladoc Health Inc (TDOC) Q2 2025 Earnings Call Highlights: Strong Integrated Care Growth Amid ... - Yahoo.co
Teladoc Health Reports Q2 2025 Earnings - TipRanks
Teladoc Health 2025 Q2 Earnings Beats Expectations as Net Loss Narrows by 96% - AInvest
Teladoc's Strategic Rebalancing: Can Discipline and Margin Expansion Offset Revenue Headwinds? - AInvest
Teladoc Health's Strategic Turnaround: A Path to Recovery Amid Earnings Volatility? - AInvest
Teladoc Health in charts: U.S. revenue continues to decline in Q2 - MSN
Teladoc Health's Strategic Turnaround and Long-Term Growth Catalysts in 2025 - AInvest
Teladoc Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:TDOC) - Seeking Alpha
Teladoc’s Revenue Slips, But Still Beats Expectations - Finimize
Teladoc Health Q2 2025 Earnings Call Transcript - MarketBeat
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Teladoc Health's Q2 2025: Can Strategic Pivots and Cash Flow Sustain Growth? - AInvest
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Teladoc Inc Q2 2025 beats earnings expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Teladoc Inc Q2 2025 beats earnings expectations - Investing.com
Post-Earnings Momentum: High-Conviction Buys in LendingClub, Qorvo, and Teladoc Health - AInvest
Teladoc Health Reports Smaller-Than-Expected Q2 Loss, Revenue Tops Estimates - Benzinga
Teladoc (NYSE:TDOC) Posts Better-Than-Expected Sales In Q2 - Yahoo Finance
Teladoc Q2 revenue down 2% but beats expectations - MarketScreener
Teladoc shares jump 6% on narrower-than-feared Q2 loss, revenue beats By Investing.com - Investing.com South Africa
Teladoc Inc earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Teladoc Q2 2025 slides: Revenue decline continues as BetterHelp struggles - Investing.com Australia
Teladoc Health Reports Second Quarter 2025 Results - TradingView
Press Release: Teladoc Health Reports Second Quarter 2025 Results - 富途牛牛
The Gen Z Mental Health Revolution: How Digital Therapy Platforms Are Reshaping the Future of Wellness - AInvest
Teladoc extends gains as Citron says it’s a “coiled spring” at current valuation - MSN
Wingspan Secures $24M Series B as Teladoc Among Major Clients Using New HR Tech Platform - Stock Titan
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):